Evaluation of SHetA2 Analogs as Anti‐Cancer Agents on Human Prostate Cancer Cells

MLA

Scott Huang, et al. “Evaluation of SHetA2 Analogs as Anti‐Cancer Agents on Human Prostate Cancer Cells.” The FASEB Journal, vol. 32, Apr. 2018. EBSCOhost, https://doi.org/10.1096/fasebj.2018.32.1_supplement.836.11.

APA

Scott Huang, Shengquan Liu, Victor Ly, Purva Kane, Allen Chan, & Vanishree Rajagopalan. (2018). Evaluation of SHetA2 Analogs as Anti‐Cancer Agents on Human Prostate Cancer Cells. The FASEB Journal, 32. https://doi.org/10.1096/fasebj.2018.32.1_supplement.836.11

Chicago

Scott Huang, Shengquan Liu, Victor Ly, Purva Kane, Allen Chan, and Vanishree Rajagopalan. 2018. “Evaluation of SHetA2 Analogs as Anti‐Cancer Agents on Human Prostate Cancer Cells.” The FASEB Journal 32 (April). doi:10.1096/fasebj.2018.32.1_supplement.836.11.